Loading...

APC anti-human CD206 (MMR) Antibody

Pricing & Availability
Clone
15-2 (See other available formats)
Regulatory Status
RUO
Other Names
MMR (macrophage mannose receptor), MR (mannose receptor), CD206, MRC1
Isotype
Mouse IgG1, κ
Ave. Rating
Submit a Review
Product Citations
publications
15-2_APC_090707
GM-CSF- stimulated (day-3) human monocytes stained with 15-2 APC
  • 15-2_APC_090707
    GM-CSF- stimulated (day-3) human monocytes stained with 15-2 APC
Compare all formats See APC spectral data
Cat # Size Price Quantity Check Availability Save
321109 25 tests 120€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
321110 100 tests 252€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Macrophage mannose receptor (MMR) is a 162-175 kD type I membrane protein also known as CD206, MRC1, or mannose receptor (MR). It is a pattern recognition receptor (PRR) that belongs to C-type lectin superfamily. MMR is expressed on macrophages, dendritic cells, and hepatic or lymphatic endothelial cells, but not on monocytes. MMR recognizes a range of microbial carbohydrates bearing mannose, fucose, or N-acetyl glucosamine. MMR mediates endocytosis and phagocytosis, induces activation of macrophages and antigen presentation, plays an important role in host defense, and provides a link between innate and adaptive immunity.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Human
Antibody Type
Monoclonal
Host Species
Mouse
Immunogen
Purified human mannose receptor
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA)
Preparation
The antibody was purified by affinity chromatography, and conjugated with APC under optimal conditions.
Concentration
Lot-specific (to obtain lot-specific concentration and expiration, please enter the lot number in our Certificate of Analysis online tool.)
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is 5 µl per million cells in 100 µl staining volume or 5 µl per 100 µl of whole blood.

Excitation Laser
Red Laser (633 nm)
Application Notes

The 15-2 antibody blocks the interaction of MMR with its ligand, and inhibits mannose receptor-mediated degradation of t-PA by macrophages. Additional reported applications of this antibody (for the relevant formats) include: Western blotting1, blocking of ligand binding1,2, immunofluorescence3, and immunohistochemical staining of acetone-fixed frozen tissue sections1. The Utra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 321149 and 321150).

Application References
  1. Noorman F, et al. 1997. J. Leukocyte Biol. 61:63. (WB, IHC, Block)
  2. Barrett-Bergshoeff M, et al. 1997. Thromb Haemost. 77:718. (Block)
  3. Kato M, et al. 2007. J. Immunol. 179:6052. (IF)
Product Citations
  1. Cui J, et al. 2021. J Cell Mol Med. 25:5586. PubMed
  2. Murugesan G, et al. 2022. Biomedicines. 10:. PubMed
  3. Sefik E, et al. 2022. Nature. 606:585. PubMed
  4. McEvoy CM, et al. 2022. Nat Commun. 13:7634. PubMed
  5. He X, et al. 2023. Int J Biol Sci. 19:331. PubMed
  6. Yoshimura T, et al. 2013. PLoS One. 8:e58791. PubMed
  7. Wang X, et al. 2019. Cell Res. 29:787. PubMed
  8. Wang X, et al. 2022. Oncogene. 41:4259. PubMed
  9. Jiang Y, et al. 2023. Sci Adv. 9:eadc8933. PubMed
  10. Xu J, et al. 2023. J Immunother Cancer. 11:. PubMed
  11. Ji T, et al. 2023. Oncogenesis. 12:31. PubMed
  12. Wu L, et al. 2023. Cell Res. . PubMed
  13. Song D, et al. 2021. Commun Biol. 4:500. PubMed
  14. Alcántara‐Hernández M et al. 2017. Immunity. 47(6):1037-1050 . PubMed
  15. Wang F, et al. 2018. Oncogenesis. 7:41. PubMed
  16. de Tymowski C et al. 2019. Cell reports. 27(3):762-775 . PubMed
  17. Bekere I, et al. 2021. PLoS Pathog. 17:e1010074. PubMed
  18. Hou ZH, et al. 2020. Am J Physiol Cell Physiol. 318:C649. PubMed
  19. Wu T, et al. 2022. Cell Death Dis. 13:624. PubMed
  20. Vijayakumar B, et al. 2022. Immunity. . PubMed
  21. Sohrabi Y, et al. 2020. Front Immunol. 11:353. PubMed
  22. Wang X, et al. 2021. Front Physiol. 12:644903. PubMed
  23. Yang HL, et al. 2020. Am J Reprod Immunol. 84:e13261. PubMed
  24. Cui L, et al. 2021. Am J Reprod Immunol. 86:e13436. PubMed
  25. Yang L, et al. 2020. Cell Stem Cell. 27(1):125-136. PubMed
  26. Terenzi DC, et al. 2021. STAR Protoc. 2:100311. PubMed
  27. Nguyen A, et al. 2014. J Biol Chem. 289:1688. PubMed
  28. Shinohara H, et al. 2017. J Immunol. 10.4049/jimmunol.1700167. PubMed
  29. Edin S, et al. 2013. PLoS One. 18:74982. PubMed
  30. Warmuth S, et al. 2022. Oncoimmunology. 10:2004661. PubMed
  31. , et al. 2021. Eur J Immunol. 51:2708. PubMed
  32. Unger A et al. 2018. Frontiers in immunology. 1.364583333 . PubMed
  33. Sefik E, et al. 2021. Nat Biotechnol. . PubMed
  34. Lundholm M, et al. 2015. Sci Rep. 5: 15651. PubMed
  35. Sohrabi Y, et al. 2019. Front Immunol. 9:3155. PubMed
  36. Arlt A, et al. 2020. Mol Oncol. 14:571. PubMed
  37. Blaszczak AM, et al. 2019. J Diabetes Res. 2019:8124563. PubMed
  38. O'Regan N, et al. 2014. PLoS Negl Trop Dis. 8:3206. PubMed
  39. Deng W, et al. 2015. Clin Immunol. . PubMed
  40. Khan A, et al. 2022. Commun Biol. 5:480. PubMed
  41. Bravo-Flores E, et al. 2018. Int J Mol Sci. 19:E1074. PubMed
  42. Liu Y, et al. 2022. Clin Transl Med. 12:e654. PubMed
  43. Stempin CC, et al. 2021. Cancers (Basel). 13:. PubMed
  44. Que Y, et al. 2021. Front Immunol. 12:653030. PubMed
  45. Li Z, et al. 2020. J Immunol. 2589:204. PubMed
  46. Ray SC, et al. 2018. J Immunol. 200:3568. PubMed
  47. Wang YJ, et al. 2021. Sci Rep. 11:8054. PubMed
  48. Zhang B, et al. 2020. Cell Death Dis. 0.973611111. PubMed
  49. Li B, et al. 2019. Oncogenesis. 8:17. PubMed
RRID
AB_571884 (BioLegend Cat. No. 321109)
AB_571884 (BioLegend Cat. No. 321110)

Antigen Details

Structure
Type I membrane protein, Pattern Recognition Receptor (PRR) family, C-type lectin superfamily, 162-175 kD
Distribution

Macrophages, dendritic cells, hepatic and lymphatic endothelial cells

Function
Pathogen binding, facilitate phagocytosis and endocytosis, macrophage activation and antigen presentation
Ligand/Receptor
Mannose, fucose, N-acetyl glucosamine
Cell Type
Dendritic cells, Endothelial cells, Macrophages
Biology Area
Cell Biology, Immunology, Neuroscience, Neuroscience Cell Markers
Molecular Family
CD Molecules
Antigen References

1. Mason D, et al. Eds. 2002. Leukocyte Typing VII. Oxford University Press. p303
2. Wileman TE, et al. 1986. P. Natl. Acad. Sci. USA 83:2501.
3. Apostolopoulos V and McKenzie IF. 2001. Curr. Mol. Med. 1:469.
4. Le Cabec V, et al. 2005. J. Leukocyte Biol. 77:934.
5. Barrett-Bergshoeff M, et al. 1997. Thromb. Haemostatis 77:718.

Gene ID
4360 View all products for this Gene ID
UniProt
View information about CD206 on UniProt.org

Other Formats

View All CD206 Reagents Request Custom Conjugation
Description Clone Applications
Purified anti-human CD206 (MMR) 15-2 FC,WB,ICC,IHC-F
FITC anti-human CD206 (MMR) 15-2 FC
PE anti-human CD206 (MMR) 15-2 FC
PE/Cyanine5 anti-human CD206 (MMR) 15-2 FC
APC anti-human CD206 (MMR) 15-2 FC
Alexa Fluor® 488 anti-human CD206 (MMR) 15-2 FC
Alexa Fluor® 647 anti-human CD206 (MMR) 15-2 FC
Biotin anti-human CD206 (MMR) 15-2 FC
APC/Cyanine7 anti-human CD206 (MMR) 15-2 FC
PerCP/Cyanine5.5 anti-human CD206 (MMR) 15-2 FC
PE/Cyanine7 anti-human CD206 (MMR) 15-2 FC
Brilliant Violet 421™ anti-human CD206 (MMR) 15-2 FC
Purified anti-human CD206 (MMR) (Maxpar® Ready) 15-2 FC,CyTOF®
Alexa Fluor® 700 anti-human CD206 (MMR) 15-2 FC
PE/Dazzle™ 594 anti-human CD206 (MMR) 15-2 FC
APC/Fire™ 750 anti-human CD206 (MMR) 15-2 FC
Brilliant Violet 711™ anti-human CD206 (MMR) 15-2 FC
Brilliant Violet 510™ anti-human CD206 (MMR) 15-2 FC
Brilliant Violet 605™ anti-human CD206 (MMR) 15-2 FC
Brilliant Violet 785™ anti-human CD206 (MMR) 15-2 FC
TotalSeq™-A0205 anti-human CD206 (MMR) 15-2 PG
TotalSeq™-B0205 anti-human CD206 (MMR) 15-2 PG
TotalSeq™-C0205 anti-human CD206 (MMR) 15-2 PG
Ultra-LEAF™ Purified anti-human CD206 (MMR) 15-2 FC,WB,ICC,IHC-F
Pacific Blue™ anti-human CD206 (MMR) 15-2 FC
PE/Fire™ 700 anti-human CD206 (MMR) 15-2 FC
TotalSeq™-D0205 anti-human CD206 (MMR) 15-2 PG
Spark NIR™ 685 anti-human CD206 (MMR) 15-2 FC
Spark Red™ 718 anti-human CD206 (MMR) (Flexi-Fluor™) 15-2 FC
Brilliant Violet 650™ anti-human CD206 (MMR) 15-2 FC
Spark Blue™ 574 anti-human CD206 (MMR) (Flexi-Fluor™) 15-2 FC
Spark Blue™ 550 anti-human CD206 (MMR) (Flexi-Fluor™) 15-2 FC
Go To Top Version: 1    Revision Date: 11.30.2012

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account